No abstract available
Keywords:
adverse effects; atherosclerosis; data science; hydroxymethylglutaryl-CoA reductase inhibitors.
Publication types
-
Randomized Controlled Trial
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Atherosclerosis*
-
Cardiovascular Diseases*
-
Decision Support Systems, Clinical*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
-
Primary Prevention
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors